Bluejay Diagnostics, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
S-1/A: Bluejay Diagnostics Announces Proposed Public Offering to Fund FDA Approval Efforts and Repay Debt
Bluejay Diagnostics is offering 2,906,977 units, each consisting of one share of common stock (or a prefunded warrant), two Class C warrants, and one Class D warrant, to raise capital for FDA approval activities and debt repayment.
NASDAQ
Bluejay Diagnostics is offering units consisting of common stock or pre-funded warrants, along with Class C and Class D warrants, in a firm commitment underwritten offering.